A phase II clinical trial of ipilimumab/nivolumab combination immunotherapy in patients with rare upper gastrointestinal, neuroendocrine, and gynecological malignancies.

被引：5

作者：

Klein, Oliver

Kee, Damien

Markman, Ben

Lee, Rachael Chang

Michael, Michael

Mileshkin, Linda R.

Scott, Clare L.

Linklater, Richelle

Menon, Sid

Tebbutt, Niall C.

Palmer, Jodie

Behren, Andreas

Cebon, Jonathan S.

机构：

[1] Austin Hlth, Med Oncol Unit, Heidelberg, Vic, Australia

[2] Peter MacCallum Canc Ctr, East Melbourne, Australia

[3] Monash Hlth, Melbourne, Vic, Australia

[4] Monash Univ, Melbourne, Vic, Australia

[5] Austin Hlth, Melbourne, Vic, Australia

[6] Peter MacCallum Canc Ctr, Div Canc Med, Melbourne, Vic, Australia

[7] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[8] Royal Melbourne Hosp, Parkville, Vic, Australia

[9] Olivia Newton John Canc Res Inst, Melbourne, Vic, Australia

来源：

关键词：

D O I：

10.1200/JCO.2019.37.15_suppl.2570

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2570

引用

页数：2